![Jennifer Buell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 775 975 $ al 31/05/2026
Dr. Jennifer S.
Buell is a President, Chief Executive Officer & Director at MiNK Therapeutics, Inc., an Independent Director at Protagenic Therapeutics, Inc., a Chief Executive Officer at AgenTus Therapeutics Ltd. and a Chief Executive Officer at AgenTus Therapeutics SA. She is on the Board of Directors at Agenus, Inc., MiNK Therapeutics, Inc. and Protagenic Therapeutics, Inc. She received her graduate degree from Tufts University and a doctorate degree from Tufts University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MINK THERAPEUTICS, INC. 1,16 % | 23/04/2026 | 57.942 ( 1,16 % ) | 706 892 $ | 31/05/2026 |
AGENUS INC. 0,05 % | 24/04/2026 | 19.738 ( 0,05 % ) | 69 083 $ | 31/05/2026 |
| 30/11/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PROTAGENIC THERAPEUTICS, INC. | Director/Miembro de la Junta | 18/07/2020 |
| MINK THERAPEUTICS, INC. | Director Ejecutivo | 01/02/2021 |
| AGENUS INC. | Director/Miembro de la Junta | 11/06/2024 |
AgenTus Therapeutics SA | Director Ejecutivo | - |
AgenTus Therapeutics Ltd. | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| AGENUS INC. | Presidente | 31/12/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagenic Therapeutics, Inc.
 Protagenic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that engages in discovery and development of therapeutics to treat stress-related neuropsychiatric & mood disorders | Health Technology |
MiNK Therapeutics, Inc.
 MiNK Therapeutics, Inc. BiotechnologyHealth Technology Provides bio pharmaceutical services | Health Technology |
AgenTus Therapeutics Ltd. | |
AgenTus Therapeutics SA |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
